Johanne Lade‐Keller

<i><scp>BRAF</scp></i> mutations in conjunctival melanoma: investigation of incidence, clinicopathological features, prognosis and paired premalignant lesions

Ann‐Cathrine Larsen, Christina Dahl, Christina M. Dahmcke et al. · Acta Ophthalmologica · 2016 · 108 citations · Full text

Medicine, Oncology, Pathology +17

E- to N-cadherin switch in melanoma is associated with decreased expression of phosphatase and tensin homolog and cancer progression

Johanne Lade‐Keller, Rikke Riber‐Hansen, Per Guldberg et al. · British Journal of Dermatology · 2013 · 69 citations

Medicine, Cancer Biology, Molecular Biology +17

Evaluation of BRAF Mutation Testing Methodologies in Formalin-Fixed, Paraffin-Embedded Cutaneous Melanomas

Johanne Lade‐Keller, Kirsten M. Rømer, Per Guldberg et al. · Journal of Molecular Diagnostics · 2012 · 69 citations

Medicine, Oncology, Pathology +13

KIT Is a Frequent Target for Epigenetic Silencing in Cutaneous Melanoma

Christina Dahl, Cecilie Abildgaard, Rikke Riber‐Hansen et al. · Journal of Investigative Dermatology · 2014 · 46 citations · Full text

Medicine, Molecular Biology, Oncology +16

Immunohistochemical analysis of molecular drivers in melanoma identifies p16 as an independent prognostic biomarker

Johanne Lade‐Keller, Rikke Riber‐Hansen, Per Guldberg et al. · Journal of Clinical Pathology · 2014 · 33 citations

Medicine, Oncology, Pathology +17